Inyoung Lee

6PUBLICATIONS
23CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Data qualityPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2026
Exploring Preferences and Priorities in Advanced Parkinson's Disease: A Discrete Choice Experiment.

Pablo Arija, Josefa Domingos, Irene A Malaty

|Jan 25, 2024
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type.

Pratyusha Vadagam, Dexter Waters, Inyoung Lee

|Oct 13, 2023
Real-world utilization of lenvatinib and pembrolizumab combination therapy for the treatment of endometrial cancer in the USA.

Keiko Wada, Jingchuan Zhang, Inyoung Lee

|Jul 29, 2020
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.

Inyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford

|Jul 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.

Inyoung Lee, Todd A Lee, Stephanie Y Crawford

|Jul 24, 2019
Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.

Inyoung Lee, Sruthi Adimadhyam, Edith A Nutescu

Pageof 1

Frequent Collaborators

3 joint publications

Gregory S Calip

2 joint publications

Todd A Lee

2 joint publications

Stephanie Y Crawford

2 joint publications

Jeremy D Jokinen